Comparative Impacts of Two Anesthesia Methods on Peripheral Tissue Oxygenation in the Upper Limb
COMPARISON OF THE EFFECTS OF GENERAL ANESTHESIA AND INTERSCALENE BLOCK ON BRACHIAL ARTERY BLOOD VOLUME FLOW, PERFUSION INDEX AND PERIPHERAL REGIONAL TISSUE OXYGENATION IN UPPER EXTREMITY SURGERY
1 other identifier
interventional
50
1 country
1
Brief Summary
This study will aim to compare the effects of two different anesthesia techniques-general anesthesia (GA) and interscalene brachial plexus block (ISB)-on forearm tissue oxygenation in patients undergoing shoulder surgery. A total of 49 patients aged 18 to 65 will be enrolled. After standard monitoring, a pulse oximeter will be placed on the second finger of the operative limb, and a regional oxygen saturation (rSO₂) sensor will be applied to the forearm to measure the perfusion index (PI) and rSO₂. Brachial artery parameters will be evaluated using ultrasound imaging approximately 2-3 cm proximal to the antecubital fossa. Patients will be assigned to either the GA group (Group 1) or the ISB group (Group 2). Mean arterial pressure (MAP), heart rate (HR), peripheral oxygen saturation (SpO₂), flow volume (FV), brachial artery diameter (BAD), and near-infrared spectroscopy (NIRS) variables (rSO₂, ΔcHbi, ΔO₂Hbi, ΔHHbi), along with PI values, will be recorded at baseline (before the procedure) and at 10, 20, 30, and 60 minutes following the completion of the block procedure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 15, 2024
CompletedFirst Submitted
Initial submission to the registry
July 17, 2025
CompletedFirst Posted
Study publicly available on registry
March 4, 2026
CompletedMarch 4, 2026
March 1, 2026
3 months
July 17, 2025
March 1, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Brachial Artery Flow Volume
Flow volume of the brachial artery will be measured using ultrasound to evaluate changes in blood flow during and after anesthesia.
Baseline, and at 10, 20, 30, and 60 minutes after block completion.
Secondary Outcomes (2)
Forearm Tissue Oxygenation and Perfusion
Baseline (pre-procedure), and at 10, 20, 30, and 60 minutes after block completion.
Perfusion Index (PI)
Baseline, and at 10, 20, 30, and 60 minutes after block completion.
Study Arms (2)
Group GA
ACTIVE COMPARATORParticipants in this group will receive general anesthesia using standard induction and maintenance protocols. No regional block will be administered. Hemodynamic parameters, brachial artery flow, and tissue oxygenation values will be monitored throughout the procedure.
Group ISB
ACTIVE COMPARATORParticipants in this group will receive an ultrasound-guided interscalene brachial plexus block as the sole anesthesia technique. No general anesthesia will be administered. Hemodynamic parameters, brachial artery flow, and tissue oxygenation values will be monitored throughout the procedure.
Interventions
General anesthesia will be administered using standard intravenous induction agents (e.g., propofol, fentanyl) and maintenance with inhalational agents as per institutional protocols. No regional block will be performed.
An ultrasound-guided interscalene brachial plexus block will be performed as the sole anesthesia technique. Local anesthetic will be injected around the brachial plexus roots at the level of the interscalene groove to provide regional anesthesia for shoulder surgery.
Eligibility Criteria
You may qualify if:
- Patients aged between 18 and 65 years
- Undergoing shoulder surgery between December 15, 2023, and March 15, 2024
- Provided written informed consent to participate in the study
You may not qualify if:
- Patients who refuse to participate in the study
- American Society of Anesthesiology (ASA) physical status classification of III or IV and above
- Contraindications to interscalene block
- Inability to cooperate during the procedure
- Patients with renal failure
- Patients with hepatic failure
- Pregnant or breastfeeding women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sakarya University Training and Research Hospital
Sakarya, 54000, Turkey (Türkiye)
Study Officials
- PRINCIPAL INVESTIGATOR
Halil Kızılışık, Specialist
Sakarya University Training and Research Hospital
- STUDY DIRECTOR
Onur Palabıyık, Assoc. Prof.
Sakarya University Training and Research Hospital
- STUDY CHAIR
Özge Pekşen Kızılışık, Specialist
Sakarya University Training and Research Hospital
- STUDY CHAIR
Muhammed Halit tekeci, Specialist
Sakarya University Training and Research Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Participants and the individual performing outcome measurements (MAP, HR, SpO₂, NIRS, PI, and ultrasound-based parameters) will be blinded to group assignments to minimize assessment bias.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Anesthesiology and Reanimation Specialist, M.D.
Study Record Dates
First Submitted
July 17, 2025
First Posted
March 4, 2026
Study Start
December 15, 2023
Primary Completion
March 15, 2024
Study Completion
June 15, 2024
Last Updated
March 4, 2026
Record last verified: 2026-03